Difference between revisions of "Pharm Plan Agenda 2014.10.02"

From IHE Wiki
Jump to: navigation, search
(Replaced content with "== Welcome == * Participants * Review and Approve Agenda == Work program 2015/2016 == = Medication Management Terms and Definitions = = Supply = White paper - Ongoing...")
(Undo revision 90894 by Costateixeira (talk))
 
Line 4: Line 4:
 
* Review and Approve Agenda
 
* Review and Approve Agenda
  
== Work program 2015/2016 ==
 
  
= Medication Management Terms and Definitions =  
+
== Schedule 2014/2015 ==
 +
* Current version:
 +
:* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Schedule/Schedule_2014-2015_v0.3.doc ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Schedule/Schedule_2014-2015_v0.3.doc]
  
= Supply =
+
* F2F meeting status
White paper - Ongoing, no new expected content
+
:* Regular IHE F2F meeting : 28-29 October 2014, Ghent, Belgium
Profiles - start early Jan
+
:* IHE Joint meeting with ITI, PCC and QRPH : 24-25 February 2015, ASIP Santé Offices, Paris, France
 +
:* IHE Joint meeting with SIG HL7 Pharmacy : 15 May 2015, Paris, France
 +
:* Regular IHE F2F meeting : 18-19 June 2015, Chania (Crete), Greece
  
= "Common" profile =
 
  
 +
== Publication of profiles of last season 2013/2014 ==
 +
* Versions returned from final editorial process
 +
:* [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2014/TF/ReturnedForReviewBeforePublishing ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2014/TF/ReturnedForReviewBeforePublishing]
 +
* Status
  
= Medication Documentation WP =
 
  
 +
== Incoming proposals ==
 +
* FHIR
 +
:* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_FHIR_v1.docx ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_FHIR_v1.docx]
  
= Formulary / Catalog =
+
* Supply of Healthcare Products
 +
:* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_Supply_v1.docx ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_Supply_v1.docx]
  
== AOB ==
+
* Healthcare Products Catalog interoperability
 +
:* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_Catalog_v1.docx ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_Catalog_v1.docx]
  
News
+
* Medication Treatment
 +
:* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_MedicationTreatment_v1.docx ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_MedicationTreatment_v1.docx]
 +
:* Proposal:
 +
::* Introduce another layer above the "logistics" layer (PRE, DIS, PADV) named "Medication Treatment"
 +
::* This layer shall be the home for "Medication Treatment" elements and their changes
 +
:::* Medication Treatment Entries shall be very similar to PRE. Thus Medication Treatment Entries shall have the Prescription Item Entry as parent with the following additional constraints:
 +
::::* no lotNumber/expirationDate/Repeats
 +
::::* Prescriber shall be renamed to "Medication Treatment Manager" (name tbd)
 +
::::* Amount of consumable might be removed (tbd)
 +
:::* Changes to "Medication Treatment" entries could be PADVs (must shall be checked in detail). If yes, they need an additional reference to Medications to indicate that the commend is related to this new information element
 +
::* Needed changes to existing profiles:
 +
:::* We need additional references in PRE, DIS to relate them to "Medication" (PADVs to PREs and DISes are already linked to them and thus also to a Medication above)
 +
:::* PML must be extended to carry those new Medication entries
 +
::* Other suggestions for the name of this layer: "Medication Planning Entry", "Medication Therapy Entry", Medication Profile Entry", "Medication Management Entry" (not good)
  
  
 +
== Existing pending proposals ==
 +
* Pharmacy Administration
 +
:* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/PharmacyAdministration ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/PharmacyAdministration]
 +
:* Proposal:
 +
::* Take up the work and complete it within this season
  
  
 +
== IHE Radiology cross-domain work ==
 +
* Possible cross-domain work (Jose)
 +
:* Contrast management (ordering and inventory control). This would then link to our Cross-domain Supply work item
 +
:* Contrast reporting (patient repositories). This would link to our Medication Data management, since it is a new source of "medication" data.
  
  
 +
== ISO liaison ==
 +
* Upcoming ISO meeting in Berlin
 +
* Commented document by Leonidas prEN ISO/DIS 17523 ‘Requirements for electronic prescriptions’
 +
:* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Other/ISO%2017523%20ePrescriptions ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Other/ISO%2017523%20ePrescriptions]
  
[[Pharmacy Technical Committee]]
+
 
 +
== Any other business ==
 +
 
 +
 
 +
== Next Meeting ==
 +
* F2F Meeting in Ghent
 +
 
 +
 
 +
[[Pharmacy Planning Committee]]
  
 
[[Category: Agenda]]
 
[[Category: Agenda]]

Latest revision as of 09:11, 1 December 2015

Welcome

  • Participants
  • Review and Approve Agenda


Schedule 2014/2015

  • Current version:
  • F2F meeting status
  • Regular IHE F2F meeting : 28-29 October 2014, Ghent, Belgium
  • IHE Joint meeting with ITI, PCC and QRPH : 24-25 February 2015, ASIP Santé Offices, Paris, France
  • IHE Joint meeting with SIG HL7 Pharmacy : 15 May 2015, Paris, France
  • Regular IHE F2F meeting : 18-19 June 2015, Chania (Crete), Greece


Publication of profiles of last season 2013/2014

  • Versions returned from final editorial process
  • Status


Incoming proposals

  • FHIR
  • Supply of Healthcare Products
  • Healthcare Products Catalog interoperability
  • Medication Treatment
  • Introduce another layer above the "logistics" layer (PRE, DIS, PADV) named "Medication Treatment"
  • This layer shall be the home for "Medication Treatment" elements and their changes
  • Medication Treatment Entries shall be very similar to PRE. Thus Medication Treatment Entries shall have the Prescription Item Entry as parent with the following additional constraints:
  • no lotNumber/expirationDate/Repeats
  • Prescriber shall be renamed to "Medication Treatment Manager" (name tbd)
  • Amount of consumable might be removed (tbd)
  • Changes to "Medication Treatment" entries could be PADVs (must shall be checked in detail). If yes, they need an additional reference to Medications to indicate that the commend is related to this new information element
  • Needed changes to existing profiles:
  • We need additional references in PRE, DIS to relate them to "Medication" (PADVs to PREs and DISes are already linked to them and thus also to a Medication above)
  • PML must be extended to carry those new Medication entries
  • Other suggestions for the name of this layer: "Medication Planning Entry", "Medication Therapy Entry", Medication Profile Entry", "Medication Management Entry" (not good)


Existing pending proposals

  • Pharmacy Administration
  • Take up the work and complete it within this season


IHE Radiology cross-domain work

  • Possible cross-domain work (Jose)
  • Contrast management (ordering and inventory control). This would then link to our Cross-domain Supply work item
  • Contrast reporting (patient repositories). This would link to our Medication Data management, since it is a new source of "medication" data.


ISO liaison

  • Upcoming ISO meeting in Berlin
  • Commented document by Leonidas prEN ISO/DIS 17523 ‘Requirements for electronic prescriptions’


Any other business

Next Meeting

  • F2F Meeting in Ghent


Pharmacy Planning Committee